Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002)

NCT00769418 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: odanacatib
DRUG: Comparator: Placebo

Sponsor

Merck Sharp & Dohme LLC